CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2025)

CollPlant Biotechnologies (CLGN) reported Non-cash Items of $6876.0 for Q4 2025, down 97.81% on a YoY basis from $314000.0 in Q4 2024, and down 97.81% quarter-over-quarter from $314000.0 in Q4 2024.

CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2025) Analysis & Trends

CollPlant Biotechnologies has reported Non-cash Items for 7 years, with the latest figure at $6876.0 in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 97.81% year-over-year to $6876.0; the trailing twelve-month figure through Dec 2025 stood at $6876.0 (down 97.81% YoY), and the FY2025 full-year result was $6876.0, down 97.81% from the prior year.
  • Non-cash Items for Q4 2025 stood at $6876.0, down from $314000.0 in the prior quarter.
  • The five-year high for Non-cash Items was $8.2 million in Q2 2021, with the low at $6876.0 in Q4 2025.
  • Historically, Non-cash Items has averaged $2.4 million across 4 years, with a median of $732507.5 in 2023.
  • Annual changes were most pronounced in 2021 — Non-cash Items surged 425.76% — and 2025, when it tumbled 97.81%.
  • CollPlant Biotechnologies' Non-cash Items stood at $8.2 million in 2021, then plunged by 86.0% to $1.2 million in 2023, then sank by 72.72% to $314000.0 in 2024, then plunged by 97.81% to $6876.0 in 2025.
  • The last three Non-cash Items figures came in at $6876.0 (Q4 2025), $314000.0 (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 CollPlant Biotechnologies 7.20 Mn 7.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 6,876.00
Dec 31, 2025 6,876.00
Dec 31, 2024 314,000.00
Dec 31, 2024 314,000.00
Dec 31, 2023 1.15 Mn
Dec 31, 2023 1.15 Mn
Jun 30, 2021 8.22 Mn
Jun 30, 2021 8.22 Mn
Jun 30, 2020 -2.52 Mn
Jun 30, 2020 -2.52 Mn
Jun 30, 2019 -2.02 Mn
Jun 30, 2019 -2.02 Mn
Jun 30, 2018 -2.17 Mn
Jun 30, 2018 -2.17 Mn